Balyasny Asset Management
PMC

Balyasny Asset Management’s PharMerica Corporation PMC Stock Holding History

Balyasny Asset Management’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,797
Closed -$228K – 2514
2017
Q3 		$228K Buy
+7,797
New +$218K ﹤0.01% 1652
2017
Q1 		– Sell
-61,990
Closed -$1.56M – 1887
2016
Q4 		$1.56M Sell
61,990
-642,967
-91% -$16.2M 0.01% 927
2016
Q3 		$19.8M Buy
+704,957
New +$18.1M 0.11% 247
2016
Q2 		– Sell
-91,240
Closed -$2.02M – 1599
2016
Q1 		$2.02M Buy
+91,240
New +$2.43M 0.01% 693
2015
Q2 		– Sell
-12,840
Closed -$362K – 1439
2015
Q1 		$362K Buy
+12,840
New +$319K ﹤0.01% 751

Balyasny Asset Management's PMC Position: Q4 2017 in Review

Balyasny Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 7,797 shares — an estimated $228K sold.

Balyasny Asset Management first reported a position in PMC in Q1 2015 and held it in 5 quarters. The position peaked at $19.8M in Q3 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Balyasny Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Balyasny Asset Management sold 7,797 PharMerica Corporation shares in Q4 2017, an estimated $228K.
  • Balyasny Asset Management first reported a position in PharMerica Corporation in Q1 2015 and held it in 5 quarters.
  • Balyasny Asset Management's PharMerica Corporation position peaked at $19.8M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.